M
$ Value
$0
Shares
20,480
Price
$0
Filed
May 6
Insider
Name
Marton Laurence
Title
—
CIK
0001862192
Roles
Director
Transaction Details
Transaction Date
2025-05-02
Code
M
Table
Derivative
Ownership
Direct
Equity Swap
No
Shares After
—
Footnotes
Represents the reporting person's cash exercise of an outstanding stock option into shares of common stock, with no sale of such shares of common stock. | Shares subject to the option are fully vested and immediately exercisable.
Filing Info
Marton Laurence's History
| Date | Ticker | Type | Value |
|---|---|---|---|
| 2026-03-20 | RNXT | ▲ | — |
| 2026-03-20 | RNXT | ▲ | — |
| 2025-10-01 | RNXT | A | $0 |
| 2025-05-02 | RNXT | M | $3K |
| 2025-05-02 | RNXT | M | $0 |
Other Insiders at RNXT (90d)
| Insider | Bought | Sold | Last |
|---|---|---|---|
|
VOLL MARK
Chief Financial Officer
|
— | — | 2026-04-03 |
| Marton Laurence | — | — | 2026-03-20 |
|
Bagai Shaun
Chief Executive Officer
|
— | — | 2026-04-03 |
|
Agah Ramtin
Chief Medical Officer
|
— | — | 2026-04-03 |
|
Gentry Leesa
Chief Clinical Officer
|
— | — | 2026-04-03 |